AstroVirus

Astroviruses are significant yet understudied pathogens that cause gastroenteritis in humans and a range of inflammatory diseases in animals worldwide. First discovered in 1975 during an outbreak of diarrhea in humans, these viruses have since been isolated from numerous mammalian and avian species, including pigs, cats, cattle, chickens, turkeys, and even marine mammals such as sea lions and dolphins. The family name derives from the Greek word "astron," meaning star, which describes the distinctive star-like appearance of the virion surface when visualized by electron microscopy. Human astroviruses (HAstVs) are now recognised as the second or third most common cause of viral diarrhoea in young children, accounting for approximately 5-9% of paediatric gastroenteritis cases globally. Despite this high prevalence, astroviruses remain among the least characterised enteric RNA viruses, with no approved vaccines or antiviral therapies currently available. This article synthesises current knowledge on astrovirus biology, pathogenesis, molecular targets, and immune evasion strategies, highlighting recent discoveries that open new avenues for therapeutic intervention.

Figure 1. Replication cycle of human astroviruses. (Arias C F, et al. 2017)

Virion Structure and Capsid Maturation

Astrovirus particles are non-enveloped, approximately 40-45 nm in diameter, and exhibit T=3 icosahedral symmetry . The capsid is uniquely characterised by spike-like projections extending about 41 nm from the surface, creating the star-like morphology that gives the family its name . The capsid protein is initially synthesised as a full-length precursor of approximately 90 kDa (VP90), which comprises five structural domains: from N-terminus to C-terminus, these include a basic domain, the inner core (S domain), the outer core (P1 domain), the spike (P2 domain), and an acidic C-terminal domain . Capsid maturation is a dynamic, host-driven process involving two distinct proteolytic cleavage events . Intracellularly, VP90 associates with cellular membranes and is cleaved by host caspases—activated during virus-induced apoptosis—to remove the acidic domain, generating VP70 . This cleavage allows virions to dissociate from membranes and exit the cell via non-lytic mechanisms that increase intestinal epithelial permeability without causing cell death .

Pathogenesis and Clinical Manifestations

Astrovirus infection primarily targets enterocytes—epithelial cells lining the intestinal tract—without causing significant inflammatory changes or gross architectural disruption . The current model of pathogenesis suggests that diarrhoea results from apoptotic death of infected epithelial cells combined with the intrinsic enterotoxic activity of the viral capsid, which increases tight junction permeability and disrupts barrier function . Symptoms typically last 3-4 days and include diarrhoea, nausea, vomiting, fever, malaise, and abdominal pain, with disease generally being self-limiting in immunocompetent individuals . However, severe and chronic infections can occur in immunocompromised patients, young children, and the elderly . Seroprevalence studies indicate that approximately 90% of children acquire antibodies to classical HAstVs by age 5, with similar rates observed for non-classical strains in adults, suggesting that most infections are mild or asymptomatic .

Diagnosis, Surveillance, and Control

Diagnostic methods include:

• RT‑PCR and qRT‑PCR (most sensitive, for genomic detection)
• Antigen detection assays
• Electron microscopy
• Serology (ELISA, neutralization tests)

Metagenomic sequencing has accelerated the discovery of novel astroviruses in clinical and environmental samples.

Control currently relies on hygiene, sanitation, and safe food‑water practices. No specific antiviral drugs or vaccines are approved for human use. Supportive care includes rehydration and electrolyte management.

Astrovirus Antibody

Astrovirus Antigens